Karyopharm Therapeutics (KPTI)
(Delayed Data from NSDQ)
$1.09 USD
+0.02 (1.87%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.09 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.32 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | 3.03% |
ABR | 1.43 |
Earnings ESP
|
4.76% |
---|---|
Current Year | -1.25 |
Next Year | -0.88 |
EPS (TTM) | -1.27 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 36.07M | 37.83M | 145.05M | 176.74M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 38.11M | 40.21M | 148.71M | 209.72M |
Low Estimate | 33.60M | 36.22M | 140.10M | 142.70M |
Year ago Sales | 37.58M | 36.01M | 146.03M | 145.05M |
Year over Year Growth Est. | -4.02% | 5.06% | -0.67% | 21.84% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.32 | -0.30 | -1.25 | -0.88 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | NA | -0.30 | -1.20 | -1.21 |
High Estimate | -0.29 | -0.29 | -1.19 | -0.57 |
Low Estimate | -0.34 | -0.31 | -1.32 | -1.25 |
Year ago EPS | -0.29 | -0.30 | -1.25 | -1.25 |
Year over Year Growth Est. | -10.34% | 0.00% | 0.00% | 29.40% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 1 | 2 |
Up Last 30 Days | 0 | 1 | 1 | 2 |
Up Last 60 Days | 0 | 1 | 1 | 2 |
Down Last 7 Days | 2 | 3 | 2 | 2 |
Down Last 30 Days | 2 | 3 | 2 | 2 |
Down Last 60 Days | 2 | 3 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.32 | -0.30 | -1.25 | -0.88 |
7 Days Ago | -0.31 | -0.30 | -1.19 | -1.05 |
30 Days Ago | -0.31 | -0.30 | -1.19 | -1.05 |
60 Days Ago | -0.31 | -0.30 | -1.15 | -1.02 |
90 Days Ago | -0.32 | -0.33 | -1.09 | -0.94 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.30 | -0.30 | -1.22 | -0.88 |
Zacks Consensus Estimate | -0.32 | -0.30 | -1.25 | -0.88 |
Earnings ESP | 4.76% | 0.00% | 2.01% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.36 | -0.30 | -0.29 | NA |
Estimate | -0.33 | -0.29 | -0.28 | -0.34 | NA |
Difference | 0.01 | -0.07 | -0.02 | 0.05 | -0.01 |
Surprise | 3.03% | -24.14% | -7.14% | 14.71% | -3.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more